Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Support Care Cancer. 2017 Dec 27;26(6):1917–1926. doi: 10.1007/s00520-017-4026-8

Table 1.

Participant characteristics

Variable Usual Care Computerized cognitive training All participants
(n=20) (n=40) (n=60)

M (SD) n (%) M (SD) n (%) M (SD) n (%)
Age (years) 66.70 (7.81) 66.5 (8.9) 66.6 (8.5)
Race/ethnicity
 White 19 (95.0) 36 (90.0) 55 (91.7)
 African American/Black 1 (5.0) 2 (5.0) 3 (5.0)
 Other 0 (0.0) 2 (5.0) 2 (3.3)
Marital status
 Married/partnered 16 (80.0) 36 (90.0) 52 (86.7)
 Single/never married 2 (10.0) 2 (5.0) 4 (6.7)
 Divorced/separated 2 (10.0) 2 (5.0) 4 (6.7)
Years of education 16.20 (2.71) 16.7 (2.9) 16.5 (2.8)
Annual household income
 ≥$110,000 9 (45.0) 14 (37.5) 24 (40.0)
 $95,000–109,999 1 (5.0) 6 (15.0) 7 (11.7)
 $80,000–94,999 1 (5.0) 1 (2.5) 2 (3.3)
 $65,000–79,999 4 (20.0) 5 (12.5) 9 (15.0)
 $50,000–64,999 3 (15.0) 1 (2.5) 4 (6.7)
 $35,000–49,999 1 (5.0) 5 (12.5) 6 (10.0)
 $20,000–34,999 0 (0.0) 3 (7.5) 3 (5.2)
 <$20,000 1 (5.0) 1 (2.5) 2 (5.0)
 Did not report 0 (0.0) 3 (7.5) 3 (5.2)
Medical comorbidities 3.80 (3.37) 6.6 (13.9) 5.7 (11.6)
Primary Treatment
 Surgery 6 (30.0) 5 (12.5) 11 (18.3)
 Surgery and radiation therapy 4 (20.0) 6 (15.0) 11 (18.3)
 Other combination including surgery -- 7 (17.5) 7 (11.7)
 External beam radiation therapy 6 (30.0) 3 (7.5) 9 (15.0)
 Radioactive seed implantation 2 (3.3) 2 (3.3)
 Radiation therapy and seed implantation 1 (5.0) 4 (10.0) 5 (8.3)
 Androgen deprivation therapy (ADT) 1 (5.0) 6 (15.0) 8 (13.3)
 Other combination not including surgery 2 (10.0) 5 (12.5) 7 (11.7)
Time since diagnosis (years) 7.3 (4.6) 6.6 (5.9) 6.9 (5.5)
Duration of ADT (months) 45.4 (31.5) 45.8 (57.3) 45.7 (49.7)